{"id":"W4309247748","doi":"10.1002/ejhf.2738","title":"<scp>Health‐related</scp> quality of life outcomes in <scp>PARAGON‐HF</scp>","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Respicardia; Sanofi Pasteur; National Institutes of Health; Servier; Moderna; Sarepta Therapeutics; Alnylam Pharmaceuticals; Cytokinetics; American Regent; Sanofi; MyoKardia; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; AstraZeneca; Eli Lilly and Company; Daiichi-Sankyo; Amgen","keywords":"Medicine; Sacubitril; Valsartan; Sacubitril, Valsartan; Confidence interval; Internal medicine; Odds ratio; Ejection fraction; Quality of life (healthcare); Heart failure; Randomization; Randomized controlled trial; Minimal clinically important difference; Cardiology; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006558609,0.0002612629,0.00134519,0.0005496937,0.000185379,0.00002320362,0.000241726,0.00005656358,0.0002420074],"category_scores_gemma":[0.002777568,0.0002115958,0.001115,0.0005920421,0.0001020432,0.0001273017,0.0001515986,0.001603799,0.00008989067],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001710027,"about_ca_system_score_gemma":0.000498514,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005287138,"about_ca_topic_score_gemma":0.00001341861,"domain_scores_codex":[0.9932979,0.002843238,0.001892263,0.000276599,0.001251108,0.0004388762],"domain_scores_gemma":[0.9972359,0.0005891177,0.0009118581,0.0004851205,0.0002221945,0.0005558035],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00006846472,0.0006175252,0.6490647,0.0001626154,0.0008274034,0.000689091,0.004049005,0.001205768,0.001072573,0.00009346054,0.3412369,0.0009124188],"study_design_scores_gemma":[0.002916646,0.0006106311,0.5122868,0.00006133025,0.00005751359,0.0008302076,0.004515607,0.00000615562,0.00007608305,0.000008512498,0.4785991,0.00003145409],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9855358,0.003136635,0.00009490772,0.008105458,0.001154318,0.0002873086,0.00002768616,0.00004271075,0.001615196],"genre_scores_gemma":[0.9943653,0.0001551146,0.0008410195,0.001680803,0.0002556826,0.000001843887,0.00001528397,0.00007072973,0.002614159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1373621,"threshold_uncertainty_score":0.8628626,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0243482616257864,"score_gpt":0.2768634082248604,"score_spread":0.252515146599074,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}